Med. praxi. 2012;9(12):470-473

Upper dyspeptic syndrome

doc.MUDr.Bohumil Seifert, Ph.D.
Univerzita Karlova, 1. lékařská fakulta, Ústav všeobecného lékařství 1. LF UK v Praze

Dyspepsia is a group of symptoms, usually of long-term nature, that are related to digestion and localized by the patient in the area of the

digestive system. A more detailed definition and principles of approach in the practice can be found in the Society of General Practice of the

Czech Medical Association of J. E. Purkyně 2012 Guideline Update. Dyspeptic complaints are among the most common reasons for self-treatment

as well as for seeing a doctor and considerable amounts of money are spent on their diagnosis and treatment. The epidemiological

background of dyspeptic complaints has been changing; there has been a significant reduction in the prevalence of infection with Helicobacter

pylori as well as in the occurrence of peptic ulcer and gastric cancer in the Czech population. The article presents an overview of therapeutic

and preventive approaches in functional dyspepsia, peptic ulcer, gastroesophageal reflux disease, and nonsteroidal anti-inflammatory drug

gastropathy, with an emphasis on the use of the most effective antisecretory therapy, i.e. the treatment with proton pump inhibitors.

proton pump inhibitors.

Keywords: general practitioner, dyspepsia, peptic ulcer, gastroesophageal reflux disease, nonsteroidal anti-inflammatory drug gastropathy,

Published: January 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Seifert B. Upper dyspeptic syndrome. Med. praxi. 2012;9(12):470-473.
Download citation

References

  1. Seifert B, Dítě P, Bureš J, Hep A, Jirásek V, Kroupa R, Lukáš K, Vojtíšková J. Gastroenterologie. Doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře. SVL ČLS JEP 2012.
  2. Agréus L, Svärdsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001; 96: 2905-2914. Go to original source... Go to PubMed...
  3. Alander T, Svardsud K, Agreus L. Functional gastrointestinal disorder is associated with increased non-gastrointestinal healtcare consumption in the general population. International Journal of Clinical Practice 2008; 62(2): 234-240. Go to original source... Go to PubMed...
  4. Rejchrt S, a kol. Prevalence a sociodemografická charakteristika dyspepsie v České republice, Nucleus HK 2005.
  5. Bureš J, et al. Epidemiology of Helicabacter pylori Infection in the Czech Republic. Blackwell Publishing, Helicobacter 2006; 11: 56-65. Go to original source... Go to PubMed...
  6. Bureš J, Kopáčová M, et al. Significant decrease in prevalence of Helicobacter pylori in the Czech Republic, World Journal of Gastroenterology 2012; 18(32): 4412-4418. Go to original source... Go to PubMed...
  7. The Montreal Definition and Classification of Gastroesophageal Reflkux Disease: A Global Evidence-based Consensus, Am J Gastroenterol 2006; 101: 1-21.
  8. Zerbib F, Roman S, et al. Esophageal pH-Impedance Monitoring and Symptom. Analysis in GERD: A Study in Patients off and on Therapy, Am J Gastroenterol 2006; 101: 1956-1963. Go to original source... Go to PubMed...
  9. http://lekari.cgs-cls.cz/guidelines/.
  10. Gilard M, Arnaud B, Cornily JC, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study J Am Coll Cardiol 2008; 51: 256-260. Go to original source... Go to PubMed...
  11. Juurlink DN, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel, CMAJ 2009; 180(7): 713-718. Go to original source... Go to PubMed...
  12. Ray WA, Murray KT, Griffin MR, et al. Outcomes With Concurrent Use of Clopidogrel With Proton Pump Inhibitors. Ann Intern Med 2010; (152): 337-355. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.